Ipswich Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.79M | Sell |
3,575
-133
| -4% | -$63.8K | 0.38% | 57 |
|
|
2026
Q1 | $1.82M | Buy |
3,708
+8
| +0.2% | +$4.34K | 0.43% | 56 |
|
|
2025
Q4 | $2.14M | Buy |
3,700
+8
| +0.2% | +$4.52K | 0.5% | 48 |
|
|
2025
Q3 | $1.79M | Sell |
3,692
-678
| -16% | -$316K | 0.42% | 56 |
|
|
2025
Q2 | $1.77M | Sell |
4,370
-2,075
| -32% | -$868K | 0.43% | 57 |
|
|
2025
Q1 | $3.21M | Sell |
6,445
-4
| -0.1% | -$2.17K | 0.8% | 34 |
|
|
2024
Q4 | $3.35M | Sell |
6,449
-400
| -6% | -$220K | 0.81% | 35 |
|
|
2024
Q3 | $4.24M | Buy |
6,849
+3
| +0% | +$1.78K | 0.98% | 32 |
|
|
2024
Q2 | $3.79M | Buy |
6,846
+65
| +1% | +$37.2K | 0.89% | 35 |
|
|
2024
Q1 | $3.94M | Buy |
6,781
+12
| +0.2% | +$6.73K | 0.92% | 34 |
|
|
2023
Q4 | $3.59M | Buy |
6,769
+120
| +2% | +$58.1K | 0.91% | 36 |
|
|
2023
Q3 | $3.37M | Sell |
6,649
-91
| -1% | -$48.5K | 0.92% | 34 |
|
|
2023
Q2 | $3.52M | Buy |
6,740
+8
| +0.1% | +$4.32K | 0.93% | 33 |
|
|
2023
Q1 | $3.88M | Sell |
6,732
-118
| -2% | -$66.5K | 1.06% | 30 |
|
|
2022
Q4 | $3.77M | Sell |
6,850
-30
| -0.4% | -$15.9K | 1.08% | 32 |
|
|
2022
Q3 | $3.49M | Sell |
6,880
-212
| -3% | -$119K | 1.11% | 27 |
|
|
2022
Q2 | $3.85M | Sell |
7,092
-21
| -0.3% | -$11.6K | 1.11% | 28 |
|
|
2022
Q1 | $4.2M | Sell |
7,113
-70
| -1% | -$40.2K | 1.04% | 29 |
|
|
2021
Q4 | $4.79M | Sell |
7,183
-175
| -2% | -$109K | 1.12% | 24 |
|
|
2021
Q3 | $4.2M | Buy |
7,358
+142
| +2% | +$77.9K | 1.08% | 26 |
|
|
2021
Q2 | $3.64M | Buy |
7,216
+188
| +3% | +$88.7K | 0.93% | 35 |
|
|
2021
Q1 | $3.21M | Buy |
7,028
+330
| +5% | +$158K | 0.9% | 38 |
|
|
2020
Q4 | $3.12M | Buy |
6,698
+165
| +3% | +$77.4K | 0.94% | 38 |
|
|
2020
Q3 | $2.88M | Sell |
6,533
-76
| -1% | -$31.4K | 0.92% | 37 |
|
|
2020
Q2 | $2.4M | Sell |
6,609
-164
| -2% | -$55K | 0.82% | 41 |
|
|
2020
Q1 | $1.92M | Sell |
6,773
-968
| -13% | -$305K | 0.76% | 46 |
|
|
2019
Q4 | $2.52M | Sell |
7,741
-25
| -0.3% | -$7.58K | 0.74% | 46 |
|
|
2019
Q3 | $2.26M | Sell |
7,766
-7
| -0.1% | -$2K | 0.72% | 47 |
|
|
2019
Q2 | $2.28M | Buy |
7,773
+35
| +0.5% | +$9.64K | 0.73% | 44 |
|
|
2019
Q1 | $2.12M | Buy |
7,738
+350
| +5% | +$87.1K | 0.69% | 45 |
|
|
2018
Q4 | $1.65M | Buy |
7,388
+40
| +0.5% | +$9.38K | 0.61% | 50 |
|
|
2018
Q3 | $1.79M | Buy |
+7,348
| New | +$1.69M | 0.61% | 55 |
|
|
2018
Q2 | – | Sell |
-7,932
| Closed | -$1.64M | – | 144 |
|
|
2018
Q1 | $1.64M | Sell |
7,932
-58
| -0.7% | -$12.2K | 0.69% | 44 |
|
|
2017
Q4 | $1.52M | Buy |
7,990
+30
| +0.4% | +$5.75K | 0.64% | 47 |
|
|
2017
Q3 | $1.51M | Sell |
7,960
-5
| -0.1% | -$906 | 0.68% | 46 |
|
|
2017
Q2 | $1.39M | Sell |
7,965
-1,320
| -14% | -$222K | 0.65% | 46 |
|
|
2017
Q1 | $1.43M | Buy |
9,285
+30
| +0.3% | +$4.58K | 0.62% | 47 |
|
|
2016
Q4 | $1.31M | Buy |
9,255
+865
| +10% | +$128K | 0.59% | 52 |
|
|
2016
Q3 | $1.33M | Buy |
8,390
+875
| +12% | +$135K | 0.65% | 50 |
|
|
2016
Q2 | $1.11M | Buy |
7,515
+6,520
| +655% | +$962K | 0.55% | 55 |
|
|
2016
Q1 | $147K | Buy |
+995
| New | +$133K | 0.07% | 146 |
|
Other funds holding TMO
RG
LT
ATO
CF
Ipswich Investment Management's TMO Position: Q2 2026 in Review
Ipswich Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 3.6% in Q2 2026, selling an estimated $63.8K and leaving 3,575 shares worth $1.79M. The position accounts for 0.38% of the portfolio, ranked #57.
Ipswich Investment Management first reported a position in TMO in Q1 2016 and has held it in 41 quarters since. The position peaked at $4.79M in Q4 2021. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Ipswich Investment Management held 3,575 shares of Thermo Fisher Scientific worth $1.79M as of Q2 2026.
- Ipswich Investment Management sold 133 Thermo Fisher Scientific shares in Q2 2026, an estimated $63.8K.
- Thermo Fisher Scientific made up 0.38% of Ipswich Investment Management's portfolio in Q2 2026, its #57 holding.
- Ipswich Investment Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 41 quarters since.
- Ipswich Investment Management's Thermo Fisher Scientific position peaked at $4.79M in Q4 2021.
- 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.